Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
FORT LAUDERDALE, Fla., Dec. 01, 2016 -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, has been selected to provide electronic data capture (EDC) services to a major research hospital in the U.S. Under the terms of a five-year, $8.4 million agreement, the research hospital named OmniComm Systems’ TrialMaster® EDC system and related services as the institution’s enterprise EDC solution across its entire portfolio of clinical research programs.
The research facility — a major institution seeking to develop cures and treatments for cancer and other catastrophic diseases — selected OmniComm’s TrialMaster to standardize clinical development programs and bring greater operational efficiency, speed and quality to the hospital’s clinical trials.
“We are honored and humbled to work alongside one of the nation’s most prestigious medical research institutes, providing advanced EDC and eSource technology to accelerate their medical research efforts,” said Stephen Johnson, president and chief operating officer at OmniComm. “This contract represents a decisive step for OmniComm in its development of services for integrated EDC. We are extremely pleased to be partnering and working with such a world-class organization.”
OmniComm’s expertise in integrating electronic medical record (EMR) systems was another important factor in the decision. Data captured in the research hospital’s EMR system will automatically import into TrialMaster. This comprehensive eSource solution will help the institution realize the following:
- Accelerate the process of data capture.
- Eliminate unnecessary duplication of data.
- Reduce transcription errors.
- Enable real-time entry of electronic source data during subject visits.
- Ensure the accuracy and completeness of data.
The ability to increase productivity and efficiency, while reducing costs, requires the integration of the clinical trial management system (CTMS) and EDC system. Integrating these systems ensures that shared datapoints are reported correctly in both systems, thereby saving time and reducing the chance for errors. The integration between TrialMaster and the hospital’s CTMS will allow the institution to proactively manage activities, such as site initiation, patient recruitment, patient safety, site payments, capacity planning and risk-based monitoring. OmniComm’s OmniConnect™ Web Service API is used to integrate a wide variety of clinical technologies such as CTMS.
OmniComm’s TrialMaster EDC was selected for its inherent flexibility, scalability, data quality and broad capabilities to provide a highly configurable, integrated EDC and patient-registry solution. Specific emphasis for TrialMaster’s selection included:
- Ability to build studies more efficiently and effectively than the hospital’s legacy systems.
- Adeptness in query management workflow.
- Intuitive interface for all key user groups.
- Dynamic and centralized monitoring for risk-based monitoring.
- Ability to export SDTM datasets directly from TrialMaster using Custom Export Utility Tool™.
- Automated transfer of significant adverse event data using SafetyLink™.
- Embedded electronic patient recorded outcomes (ePRO).
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience, based on more than 5,000 clinical trials. For more information, visit omnicomm.com.
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Dennis Constantinou OmniComm Systems, Inc. +1.954.473.1254 [email protected]
